Printer Friendly

IVAX DETERMINES NOT TO PROCEED WITH ACQUISITION OF THE SOLOPAK DIVISION OF SMITH & NEPHEW, INC.

 IVAX DETERMINES NOT TO PROCEED WITH ACQUISITION
 OF THE SOLOPAK DIVISION OF SMITH & NEPHEW, INC.
 MIAMI, June 1 /PRNewswire/ -- IVAX Corporation (AMEX: IVX) announced today that IVAX has determined not to proceed with the proposed acquisition of the Solopak Division of Smith & Nephew, Inc. The acquisition agreement was terminated pursuant to its terms after conditions to the consummation of the acquisition were not satisfied.
 IVAX Corporation is a holding company with subsidiaries involved in specialty chemicals, pharmaceuticals and medical diagnostics. IVAX' principal subsidiaries include Baker Cummins Pharmaceuticals, Inc., a developer and marketer of unique brand name pharmaceuticals; Norton Healthcare Limited, a leading manufacturer and marketer of off-patent pharmaceuticals in the United Kingdom, Ireland and other countries; Goldline Laboratories, Inc., a national marketer of off-patent prescription and over the counter pharmaceuticals in the United States; Baker Cummins Dermatologicals, Inc., a dermatological products company; Willen Drug Company, a urological products company; DVM Pharmaceuticals Inc., a veterinary products company; Diamedix Corporation, a medical diagnostics company; Delta Biologicals S.r.l., a marketer of medical diagnostic tests and instruments in Italy; and IVAX Industries, Inc., a chemical specialties business.
 -0- 6/1/92
 /CONTACT: Richard C. Pfenniger Jr., senior vice president of legal affairs of IVAX Corporation, 305-590-2309/
 (IVX) CO: IVAX Corporation; Solopak; Smith & Nephew ST: Florida IN: MTC SU: TNM


JJ-AW -- FL002 -- 5512 06/01/92 08:58 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 1, 1992
Words:226
Previous Article:NEW LIGHTING TECHNOLOGY UNVEILED AT EDISON ELECTRIC INSTITUTE MEETING
Next Article:VOLVO PENTA AND OUTBOARD MARINE TO FORM JOINT VENTURE; NEW COMPANY TO PRODUCE STERNDRIVES AND INBOARD GASOLINE MARINE ENGINES
Topics:


Related Articles
IVAX CORPORATION ANNOUNCES THE ACQUISITION OF THREE BRAND NAME PHARMACEUTICAL PRODUCTS
IVAX ENTERS INTO AGREEMENT TO ACQUIRE THE SOLOPAK DIVISION OF SMITH & NEPHEW, INC.
IVAX ACQUIRES DVM PHARMACEUTICALS, INC.
IVAX ENTERS INTO AGREEMENT TO ACQUIRE LUCHEM PHARMACEUTICALS
IVAX COMPLETES ACQUISITION OF LUCHEM PHARMACEUTICALS, INC.
IVAX ENTERS INTO AGREEMENT TO ACQUIRE CERTAIN ASSETS OF THE U.K. GENERIC PHARMACEUTICAL OPERATIONS OF MEDEVA PLC
IVAX COMPLETES ACQUISITION OF CERTAIN ASSETS OF THE U.K. GENERIC PHARMACEUTICAL OPERATIONS OF MEDEVA PLC
IVAX Completes Acquisition Of Canadian Manufacturing Facility From Glaxo Wellcome
IVAX Sells Textile Products Business to Sybron Chemicals
Smith & Nephew Enters Into an Agreement to Acquire All Outstanding Capital Stock of Orthopaedic Biosystems Ltd., Inc.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters